Hypertension, Habitual Snoring, and Adverse Pregnancy Outcomes
Advertisement
Snoring. Do you ask patients about it? It could be a sign of obstructive sleep apnea, which has been linked to high blood pressure and poorer pregnancy outcomes.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.